Share on LinkedInShare on LinkedIn

ARTICLE · 13 MARCH 2025

Market Intelligence Thought Leadership Award Winner

US Reciprocal Tariffs: Impact On Indian Pharmaceutical Exports

King, Stubb & Kasiva
King, Stubb & Kasiva
Contributor
King, Stubb & Kasiva

King, Stubb & Kasiva

King Stubb & Kasiva is few of the top corporate law firms in India with offices in Bengaluru,...

View firm profile
Explore more from King, Stubb & Kasiva

India has cemented its place as a global leader in pharmaceuticals, supplying nearly 40% of the generic drugs consumed in the US. However, a potential shift in trade policy could disrupt this dynamic.

IndiaInternational Law

Introduction

India has cemented its place as a global leader in pharmaceuticals, supplying nearly 40% of the generic drugs consumed in the US. However, a potential shift in trade policy could disrupt this dynamic. The US is considering imposing a 10% tariff on Indian pharmaceutical imports, mirroring the tariff India applies to American drugs. While this move aims at balancing trade terms, it could lead to higher costs for US consumers, reduced competitiveness for Indian exporters, and possible supply chain disruptions. The impact on India's economy, pharmaceutical industry, and global healthcare accessibility remains a pressing concern for both nations.

Background: India's Pharmaceutical Dominance and US Trade

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

https://ksandk.com/

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from